 Deutsche Bank AG raised its position in shares of Fulcrum Therapeutics NASDAQ:FULC by 207.0 during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission SEC. The institutional investor owned 4,636 shares of the companys stock after acquiring an additional 3,126 shares during the period. Deutsche Bank AGs holdings ... 